We will use cookies and other information to optimize your experience. By continuing to browse, you consent to our use. For details, please read
Privacy Policy
×
RuenHuei Biopharmaceuticals Inc.
Language
English
繁體中文
ABOUT US
Company Overview
Juine-Ruey (JR) Chen Ph.D
Management Team
NEWS
Media
Interview
PIPELINE
Overview
Flu Vaccine Platform
C34 Adjuvant Formulation
PRODUCTS
CONTACT
Home
NEWS
ALL NEWS
18
2019.01
Development of monoglycosyalated HA (HAmg) as a universal flu vaccine.
11
2018.12
The interview of Dr. Hsiao
English
繁體中文
Language
English
繁體中文
ABOUT US
Company Overview
Juine-Ruey (JR) Chen Ph.D
Management Team
NEWS
Media
Interview
PIPELINE
Overview
Flu Vaccine Platform
C34 Adjuvant Formulation
PRODUCTS
CONTACT
